Development of albumin microspheres containing Sp H1-DNA complexes: A novel gene delivery system

References

• Adami RC, Collard WT, Gupta SA, Kwok KY, Bonadio J, Rice KG. Stability of peptide-condensed plasmid DNA formulations. J Pharm Sci 1998; 87: 678–683
   PubMed Web of Science ®Google Scholar
• Bejugam N, Uddin A, Gayakwad S, D’Souza M. Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsulation 2008; 25: 577–583
   PubMed Web of Science ®Google Scholar
• Breeuwer M, Goldfarb DS. Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell 1990; 60: 999–1008
   PubMed Web of Science ®Google Scholar
• Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment. Pharm Dev Technol 1999; 4: 491–498
   PubMed Web of Science ®Google Scholar
• Chew J, Wolfowicz C, Mao HQ, Leong K, Chua K. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 2003; 21: 2720–2729
   PubMed Web of Science ®Google Scholar
• Cremers HF, Feijen J, Kwon G, Bae YH, McVie JG. Albumin heparin microspheres as carriers for cytostatic agents. J Contr Rel 1990; 11: 167–179
   Web of Science ®Google Scholar
• Dash P, Read ML, Barrett LB, Wolfert MA, Seymour LW. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643–650
   PubMed Web of Science ®Google Scholar
• Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 1996; 93: 8578–8583
   PubMed Web of Science ®Google Scholar
• Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125–1135
   PubMed Web of Science ®Google Scholar
• Gore ME. Adverse effects of gene therapy: Gene therapy can cause leukaemia: No shock, mild horror but a probe. Gene Ther 2003; 10: 4
   Google Scholar
• Green GR. Phosphorylation of histone variant regions in chromatin: Unlocking the linker?. Biochem Cell Biol 2001; 79: 275–287
   PubMedGoogle Scholar
• Green GR, Collas P, Burrell A, Poccia DL. Histone phosphorylation during sea urchin development. Seminars in Cell Biology 1995; 6: 219–227
   PubMedGoogle Scholar
• Green GR, Lee H, Poccia DL. Phosphorylation weakens DNA binding by peptides containing multiple ‘SPKK’ sequences. J Biol Chem 1993; 288: 11247–11255
   Google Scholar
• Gupta PK, Hung CT. Albumin microspheres II. Applications in drug delivery. J Microencapsulation 1989; 6: 463–472
   PubMed Web of Science ®Google Scholar
• Heller J, Baker RW. Theory and practice of controlled release of bioactive materials. Controlled release of bioactive materials, RW Baker. Academic Press, New York 1980; 1–17
   Google Scholar
• Iwasak A, Torres CAT, Ohashi PS, Robinson HL, Barber BH. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159: 11–14
   PubMed Web of Science ®Google Scholar
• Jones C, Burton MA, Gray BN. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin. J Pharm Pharmacol 1989; 41: 813–816
   PubMed Web of Science ®Google Scholar
• Katti D, Krishnamurthi N. Preparation of albumin microspheres by improved process. J Microencapsulation 1999; 16: 231–242
   PubMed Web of Science ®Google Scholar
• Kiernan JA. Formaldehyde, formalin, paraformaldehyde and glutaraldehyde: What they are and what they do. Microscopy Today 2000; 1: 8–12
   Google Scholar
• Kramer PA. Albumin microspheres as vehicles for achieving specificity in drug delivery. J Pharm Sci 1974; 63: 1646–1647
   PubMed Web of Science ®Google Scholar
• Lee TK, Sokolski TD, Royer GP. Serum albumin beads: An injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 223–235
   Web of Science ®Google Scholar
• Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401: 517–518
   PubMed Web of Science ®Google Scholar
• Leucuta SE, Risca R, Daicoviciu D, Portutiu D. Albumin microspheres as a drug delivery system for epirubicin: Pharmaceutical, pharmacokinetic and biological aspects. Int J Pharm 1988; 41: 213–217
   Web of Science ®Google Scholar
• Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10: 935–940
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Akimoto M, Sugibayahsi K, Nadai T, Kato Y. Drug-carrier property of albumin microspheres in chemotherapy. IV. Antitumor effect of single-shot or multiple shot administration of microsphere-entrapped 5-fluorouracil on Ehrlich ascites or solid tumor in mice. Chem Pharm Bull 1980; 28: 3087–3092
   PubMed Web of Science ®Google Scholar
• Patiln GV. Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res 2003; 58: 219–247
   Web of Science ®Google Scholar
• Peppas LB. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995; 116: 1–9
   Web of Science ®Google Scholar
• Poccia D, Green GR. Nuclei and chromosomal proteins. Methods Cell Biol 1986; 27: 153–174
   PubMed Web of Science ®Google Scholar
• Poccia DL, Green GR. Packaging and unpackaging the sea urchin sperm genome. Trends Biochem Sci 1992; 176: 223–227
   Google Scholar
• Puebla I, Esseghir S, Mortlock A, Browna A, Low W. A recombinant H1 histone based system for efficient delivery of nucleic acids. J Biotechnol 2003; 5: 215–226
   Google Scholar
• Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978; 15: 261–267
   PubMed Web of Science ®Google Scholar
• Ruberti M, Lima K, Santos S. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J Drug Target 2004; 12: 195–203
   PubMed Web of Science ®Google Scholar
• Scheffel U, Rhodes BA, Natarajan TK, Wagner HN. Albumin microspheres for studies of reticuloendothelial system. J Nucl Med 1972; 13: 498–503
   PubMed Web of Science ®Google Scholar
• Sun JY, Anand-Jawa V, Chatterjee S, Wong KK. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther 2003; 10: 964–976
   PubMed Web of Science ®Google Scholar
• Tomlinson E. Microspheres delivery systems for drug targeting and controlled release. Int J Pharm Technol Prod Manuf 1983; 4: 49–57
   Google Scholar
• Torrado JJ, Cadorniga R. Albumin microcapsules, microspheres and nanoparticles as new systems of medication administration. Farm Clin 1989; 6: 724–733
   Google Scholar
• Treco DA, Selden RF. Non-viral gene therapy. Mol Med Today 1995; 1: 314–321
   PubMedGoogle Scholar
• Wang B, Merva M, Dang K, Ugen KE, Boyer J, Williams WV, et al. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. AIDS Res Hum Retroviruses 1994; 10(Suppl 2): 35–41
   Web of Science ®Google Scholar
• Widder K, Flouret G, Senyei A. Magnetic microspheres: Synthesis of a novel parenteral drug carrier. J Pharm Sci 1979; 68: 79–81
   PubMed Web of Science ®Google Scholar
• Yeboah KG, D’Souza MJ. Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines. J Microencapsulation 2008; 1: 1–14
   Google Scholar
• Yolles S, Eldrugde JE, Woodland JHR. Sustained delivery of drugs from polymer/drug mixtures. Polym News 1979; 2: 1–9
   Google Scholar